These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22285835)

  • 1. Superior methadone treatment outcome in Hmong compared with non-Hmong patients.
    Bart G; Wang Q; Hodges JS; Nolan C; Carlson G
    J Subst Abuse Treat; 2012 Oct; 43(3):269-75. PubMed ID: 22285835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in psychosocial factors in methadone maintenance: Hmong versus non-Hmong.
    Bart G
    J Ethn Subst Abuse; 2018; 17(2):108-122. PubMed ID: 29120275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
    Lister JJ; Greenwald MK; Ledgerwood DM
    J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national study of the retention of Irish opiate users in methadone substitution treatment.
    Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
    Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
    Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
    Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W
    J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the Treatment Outcome Profile among patients attending methadone maintenance treatment programs in Kunming, China.
    Wang M; Shen J; Liu X; Deng Y; Li J; Finch E; Wolff K
    J Subst Abuse Treat; 2017 Jun; 77():89-94. PubMed ID: 28476278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.
    Marsch LA; Guarino H; Acosta M; Aponte-Melendez Y; Cleland C; Grabinski M; Brady R; Edwards J
    J Subst Abuse Treat; 2014 Jan; 46(1):43-51. PubMed ID: 24060350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
    Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
    J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder.
    Wilder CM; Hosta D; Winhusen T
    J Subst Abuse Treat; 2017 Sep; 80():33-36. PubMed ID: 28755770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial.
    Moghadam MS; Alavinia M
    Pak J Pharm Sci; 2013 Sep; 26(5):985-9. PubMed ID: 24035957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone dose, take home status, and hospital admission among methadone maintenance patients.
    Walley AY; Cheng DM; Pierce CE; Chen C; Filippell T; Samet JH; Alford DP
    J Addict Med; 2012 Sep; 6(3):186-90. PubMed ID: 22694929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose versus moderate dose methadone maintenance: is there a better outcome?
    Fareed A; Casarella J; Roberts M; Sleboda M; Amar R; Vayalapalli S; Drexler K
    J Addict Dis; 2009 Oct; 28(4):399-405. PubMed ID: 20155609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
    Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
    Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
    Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
    Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.
    Reimer J; Boniakowski E; Bachner C; Weber B; Tietje W; Verthein U; Walcher S
    Subst Abuse Treat Prev Policy; 2014 Feb; 9():13. PubMed ID: 24581310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.
    Scheibe A; Shelly S; Gerardy T; von Homeyer Z; Schneider A; Padayachee K; Naidoo SB; Mtshweni K; Matau A; Hausler H; Marks M
    Addict Sci Clin Pract; 2020 Feb; 15(1):13. PubMed ID: 32085807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.